1. Home
  2. APLM vs CLWT Comparison

APLM vs CLWT Comparison

Compare APLM & CLWT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APLM
  • CLWT
  • Stock Information
  • Founded
  • APLM 2016
  • CLWT 1971
  • Country
  • APLM United States
  • CLWT Hong Kong
  • Employees
  • APLM N/A
  • CLWT N/A
  • Industry
  • APLM Blank Checks
  • CLWT Professional and commerical equipment
  • Sector
  • APLM Finance
  • CLWT Consumer Discretionary
  • Exchange
  • APLM Nasdaq
  • CLWT Nasdaq
  • Market Cap
  • APLM 6.9M
  • CLWT 8.9M
  • IPO Year
  • APLM N/A
  • CLWT 1997
  • Fundamental
  • Price
  • APLM $6.49
  • CLWT $1.15
  • Analyst Decision
  • APLM
  • CLWT
  • Analyst Count
  • APLM 0
  • CLWT 0
  • Target Price
  • APLM N/A
  • CLWT N/A
  • AVG Volume (30 Days)
  • APLM 7.8K
  • CLWT 15.4K
  • Earning Date
  • APLM 08-13-2025
  • CLWT 04-30-2025
  • Dividend Yield
  • APLM N/A
  • CLWT N/A
  • EPS Growth
  • APLM N/A
  • CLWT N/A
  • EPS
  • APLM N/A
  • CLWT 0.10
  • Revenue
  • APLM $198,000.00
  • CLWT $15,383,000.00
  • Revenue This Year
  • APLM $415.15
  • CLWT N/A
  • Revenue Next Year
  • APLM N/A
  • CLWT N/A
  • P/E Ratio
  • APLM N/A
  • CLWT $11.99
  • Revenue Growth
  • APLM N/A
  • CLWT N/A
  • 52 Week Low
  • APLM $4.47
  • CLWT $1.01
  • 52 Week High
  • APLM $35.98
  • CLWT $1.70
  • Technical
  • Relative Strength Index (RSI)
  • APLM 47.85
  • CLWT 48.83
  • Support Level
  • APLM $6.21
  • CLWT $1.07
  • Resistance Level
  • APLM $6.80
  • CLWT $1.17
  • Average True Range (ATR)
  • APLM 0.52
  • CLWT 0.04
  • MACD
  • APLM 0.00
  • CLWT 0.00
  • Stochastic Oscillator
  • APLM 51.61
  • CLWT 50.00

About APLM Apollomics Inc.

Apollomics Inc is an clinical-stage biopharmaceutical company focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company programs include vebreltinib (APL-101), a potent, selective c-Met inhibitor for the treatment of non-small cell lung cancer and other tumors with c-Met alterations, and uproleselan (APL-106), a specific E-Selectin antagonist that has the potential to be used adjunctively with standard chemotherapy to treat acute myeloid leukemia.

About CLWT Euro Tech Holdings Company Limited

Euro Tech Holdings Co Ltd is a distributor and manufacturer of technology instruments as well as an environmental engineering services provider. It is engaged in the marketing and trading of water and wastewater related process control, analytical and testing instruments, disinfection equipment, supplies, and related automation systems. There are two operating segments of the company. The Trading and manufacturing segment, which is the key revenue driver, includes distribution of water treatment equipment, laboratory instruments, analyzers, test kits, and related supplies and power generation equipment. The Engineering segment includes water and waste-water treatment engineering and air pollution control business. The majority of the revenue is generated from Hong Kong.

Share on Social Networks: